ZYME

Zymeworks Inc.

26.86

USD

-0.70

-2.54%

Sep 23, 12:19 UTC -4

Open

Zymeworks Inc. Profile

About

Zymeworks Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The companys lead product candidate includes ZW25 and ZW33 which are in clinical trial stage. Zymeworks Inc. is headquartered in Vancouver, Canada.

Info & Links

CEO

Kenneth Galbraith

Headquarters

108 PATRIOT DRIVE, SUITE A
MIDDLETOWN, DE 19709, UNITED STATES

Auditor

KPMG LLP

Share holders

Employees

264

Zymeworks Inc. Statistics

Valuation Measures

Market Capitalization²

1.92B

Enterprise Value

1.74B

Enterprise Value/EBITDA(ttm)

-11.92

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

51.24

Price to Book(mrq)

24.36

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

-749.86%

Operating Margin(ttm)

-405.31%

Profit Margin(ttm)

-1131.07%

Return on Equity(ttm)

-72.30%

Return on Invested Capital(ttm)

-104.44%

Return on Assets(ttm)

-37.18%

Income Statement

Revenue(ttm)

37.13M

Revenue Per Share(ttm)

0.52

Gross Profit(ttm)

-91.58M

EBITDA(ttm)³

-146.06M

Net Income Available to Common(ttm)

-149.99M

Diluted EPS(ttm)

-2.02

Share Statistics

Beta (5Y Monthly)

1.19

52-Week Change

62.52%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

70.96M

Dividend Yield

0.00%

Float⁴

47.18M

% Held by Insiders

33.51%

% Held by Institutions

92.89%

Balance Sheet

Total Cash(mrq)

270.70M

Total Cash Per Share(mrq)

3.81

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.32%

Quick Ratio(mrq)

6.32%

Book Value Per Share(mrq)

1.13

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.06

Free Cash Flow(ytd)

-77.88M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.